Rufloxacin
From Wikipedia, the free encyclopedia
Rufloxacin
|
|
Systematic (IUPAC) name | |
9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro- 7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid | |
Identifiers | |
CAS number | 106017-08-7 (hydrochloride) 102052-47-1 (hydrobromide) |
ATC code | J01 |
PubChem | |
Chemical data | |
Formula | C17H18FN3O3S |
Mol. mass | 363.406 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Rufloxacin is a quinolone.
|